A Phase 1, Open Label, Randomized, Four Period, Crossover, Multiple Dose Study To Assess The Pharmacokinetic Interaction Between Sitaxsentan and Tadalafil and The Effect Of Sildenafil On Sitaxsentan PK In Healthy Subjects.

Trial Profile

A Phase 1, Open Label, Randomized, Four Period, Crossover, Multiple Dose Study To Assess The Pharmacokinetic Interaction Between Sitaxsentan and Tadalafil and The Effect Of Sildenafil On Sitaxsentan PK In Healthy Subjects.

Discontinued
Phase of Trial: Phase I

Latest Information Update: 18 Jan 2012

At a glance

  • Drugs Sildenafil; Sitaxentan; Tadalafil
  • Indications Erectile dysfunction; Heart failure; Hypertension
  • Focus Pharmacokinetics
  • Sponsors Pfizer
  • Most Recent Events

    • 13 Dec 2010 Status changed from not yet recruiting to discontinued as reported by ClinicalTrials.gov.
    • 02 Dec 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top